Logo

settlement

Qiagen Settles Becton Dickinson Patent Infringement Lawsuit for $53M

BD filed the suit against NeuMoDx, now part of Qiagen, in 2019 for infringing patents related to the use of microfluidic cartridges for molecular diagnostics.

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business

The firms have agreed to transition the business to Beckman, with Quidel receiving annual payments until 2029.

Cancer Genetics Settles Failed Merger Deal With NovellusDx; Receives $6M From Interpace

Cancer Genetics announced its planned merger with NovellusDx in September 2018, but scuttled the deal with the Israeli company a few months later.

10x Genomics to Pay $25M, Cross-License Patents to End BD Infringement Suit

10x will pay Becton Dickinson $25 million over four years and the firms have agreed to refrain from engaging in a legal battle on other fronts.

PacBio, Oxford Nanopore Settle Patent Dispute in Europe

Under the terms of the agreement, Oxford Nanopore Technologies will not sell its 2D sequencing products in the UK and in Germany for five years.

Apr 20, 2018

Biotheranostics Settles False Claims Allegations With DOJ for $2M

Sep 28, 2017

Alere Settles With SEC for $13M

Nov 29, 2016

Med BioGene, Helomics Revise Licensing Agreement

Jul 22, 2015

Enzo, Siemens Resolve IP Infringement Case

Feb 9, 2015

Myriad Settles BRCA Patent Case with Quest; Only GeneDx Lawsuit Remains

Sep 17, 2014

CareDx Settles with Roche Over Allegations of Breach of Agreement

Nov 15, 2012

Alnylam, Tekmira End Litigation with $65M Settlement
Premium

May 9, 2012

Genetic Technologies, GeneSeek Settle Patent Dispute

May 2, 2012

Pacific Biosciences Settles IP Litigation with Life Technologies, Helicos

Apr 30, 2012

Vermillion, Bio-Rad Settle Claims Stemming from Sale of Proteomics Technology

Mar 7, 2012

Affymetrix Completes Repurchase of $92M of Senior Notes as Part of Settlement

Feb 14, 2012

Vermillion Receives $1M in Settlement; Moves to Nasdaq Capital Market

Feb 6, 2012

Genetic Technologies, Eurofins STA Labs Settle Infringement Dispute

Dec 1, 2011

GTG Settles Dispute, Licenses Technology to AutoImmun

Nov 28, 2011

Rosetta Defaults on Payment to Prometheus, Warns of Potential Bankruptcy Protection

Oct 27, 2011

Caliper Settles Shareholder Lawsuits Tied to Acquisition by PerkinElmer

Jul 21, 2011

GE Healthcare, Beckman Coulter Settle Nucleic Acid Sample Prep Lawsuit
Premium

May 17, 2011

U of Washington, Pharmigene Resolve IP Dispute, Reach Licensing Deal

Dec 2, 2010

Rosetta Regains US Rights to miRNA Cancer Diagnostics, Addresses QC Issue at Diagnostics Lab
Premium

Nov 23, 2010

Rosetta, Prometheus Settle Arbitration on MicroRNA Tests

Breaking News
The Scan

Time to Sit Back and Relax

NPR reports that the US National Institutes of Health has transferred the last of its eligible, former research chimpanzees to a sanctuary.

Omicron-Focused Vaccines

The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant.

Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization

In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.

Time to Act

A new report urges the UK to consider regulations to protect against the misuse of genomic technologies, according to the Guardian.